Three top investment trusts

Recent months have seen some of the toughest times for equities. Yet there are still deals to be had in investment trusts, says professional investor Peter Walls. Here, he tips three such trusts to buy now.

Each week, a professional ionvestor tells MoneyWeek where he'd put his money now. This week:Peter Walls, portfolio manager, Unicorn Asset Management.

When an old hand such as Fidelity's Anthony Bolton says the last few weeks of September 2011 were as difficult a time to be running money as he can remember, you know that times have been tough for equity investors. And with the eurozone crisis rumbling on, it takes a leap of faith to adopt Warren Buffett's mantra to be greedy when others are fearful. Even so, I think there are a number of interesting opportunities in the investment trust sector at present, which not only offer recovery potential but can also be bought at attractive discounts to net asset value (NAV).

Investment trusts that specialise in UK smaller companies generally trade at relatively wide discounts at the best of times. So it is no great surprise that ratings have deteriorated amid the recent uncertainty. Trading on an 18% discount to NAV, the Throgmorton Trust (LSE: THRG) is available at a price that almost implies that something is seriously amiss. But nothing could be further from the truth.

Performance since the appointment of the new management team in July 2008 has been second to none. The trust trades within a highly competitive peer group, in which the majority of trusts have consistently beaten the FTSE Smaller Companies Index. In the three-year period ending 9 December 2011, Throgmorton's NAV appreciated by more than 140%, compared to a rise of 47% in the FTSE All Share index. As such it would make an ideal choice for a toddler's Jisa (junior individual savings account).

Investors in BlackRock New Energy (LSE: BRNE) have had a roller-coaster ride since the trust was launched around ten years ago, with big moves in the NAV accentuated by dramatic swings in the discount. Having at times traded at a premium to NAV, the shares now sit at a discount of 20%. At that level, they appeal to my contrarian tendencies. Just as many technology funds were investing in young businesses in the technology boom of the late 1990s, BRNE started off its life with investments in early-stage companies.

The technology funds that survived the bust are now largely invested in profitable companies and this is true for BRNE too. The portfolio now features multi-billion-pound companies such as Johnson Controls and Johnson Matthey. The incredible expansion of the emerging-market middle class will undoubtedly force energy prices higher over time, increasing the economic viability of the alternative technologies represented in BRNE's portfolio.

Staying with the technology theme, I continue to favour Herald Investment Trust (LSE: HRI), where the discount has drifted back out to more than 20%. If, like me, you believe that smaller technology companies can deliver superior long-term returns, then this is a trust worth considering.

The combination of investing in relatively immature businesses operating in fast-changing, cutting-edge markets is not without considerable risk. This probably explains why Herald's underlying portfolio is so diversified in terms of the number of underlying investments. However, the 463% rise in the trusts's NAV (versus the FTSE All Share's 65% rise) since launch in 1994 suggests that the current management team have got their strategy about right.

Recommended

Imperial Brands has an 8.3% yield – but what’s the catch?
Share tips

Imperial Brands has an 8.3% yield – but what’s the catch?

Tobacco company Imperial Brands boasts an impressive dividend yield, and the shares look cheap. But investors should beware, says Rupert Hargreaves. H…
20 May 2022
Investing in drugmakers: uncommon profits from curing rare diseases
Share tips

Investing in drugmakers: uncommon profits from curing rare diseases

Treatments for medical conditions with only a small number of sufferers can still be very attractive for pharmaceutical companies and investors becaus…
20 May 2022
Share tips of the week – 20 May
Share tips

Share tips of the week – 20 May

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
20 May 2022
Delivering profits: should you buy Royal Mail shares?
Share tips

Delivering profits: should you buy Royal Mail shares?

The volume of parcels delivered by Royal Mail soared during the pandemic, and so did its profits. But it has been coming under pressure lately. So, as…
19 May 2022

Most Popular

The ten highest dividend yields in the FTSE 100
Income investing

The ten highest dividend yields in the FTSE 100

Rupert Hargreaves looks at the FTSE 100’s top yielding stocks for income investors to consider.
18 May 2022
Aviva: a share for income investors to tuck away
Share tips

Aviva: a share for income investors to tuck away

Insurance giant Aviva is one of the highest yielding stocks in the FTSE 100 – and it’s cheap, too, making it a tempting target for income investors. R…
18 May 2022
Despite the crypto crash, bitcoin still has a bright future
Bitcoin & crypto

Despite the crypto crash, bitcoin still has a bright future

Cryptocurrencies have crashed hard, with bitcoin down by more than 50% from its peak. But, says Dominic Frisby, bitcoin still has a future – it is the…
19 May 2022